Atlas Trials

Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia

Clinical trial NCT03132571 · TERMINATED

Trial details

NCT number
NCT03132571
Sponsor
Yale University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
SchizophreniaDiabetes Mellitus, Type 2Obesity
Start date
2017-06-01
Primary completion
2018-07-31
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.